Seed Media Group

Terra Sigillata

musings on medicines from the Earth

Search this blog

Profile

Abel%20sharpened%20reduced%20150px.jpg Abel Pharmboy is the nom de plume of an academic researcher and educator who holds a PhD in Pharmacology. He writes on natural product drugs and dietary supplements, academic career development, medical journalism and, occasionally, making and listening to music and, with the help of his colleague, Erleichda, wine appreciation.

Terra Sigillata is the name of the first authenticated, trademarked drug. "Why Terra Sigillata?" will tell you more about the origin of the blog name.

You can learn quickly the distinction between the fields of Pharmacology, Pharmacognosy, Pharmacy, the Pharmaceutical Sciences by clicking on the hyperlinks.

Learn more about the author and the origin of "Abel Pharmboy" here.

Please feel free to contact me off-blog by e-mail to abelpharmboy (at) gmail (dot) com.

Please read the DISCLAIMER for details on the blog's intended audience, advertising and comment policy, and how not to use the information presented herein.

DonorsChoose 2008


We comply with the HONcode standard for trustworthy health
information:
verify here.

 Subscribe in a reader

Add to Google Reader or Homepage

Subscribe in NewsGator Online

Subscribe in Bloglines

http://www.wikio.com


OpenLab2006.png Openlab 2007

Recent Posts

Recent Comments

Subscribe via Email

Stay abreast of your favorite bloggers' latest and greatest via e-mail, via a daily digest.

Sign me up!

Archives

Blogroll

« First anniversary of DrugMonkey | Main | The Friday Fermentable: Foiled and Frustrated »

About Erleichda, co-author of The Friday Fermentable

Category: CancerErleichdaResearchThe Friday FermentableWine
Posted on: January 18, 2008 3:46 PM, by Abel Pharmboy

Erleichda is the nom de plume of a guest blogger who contributes regularly to The Friday Fermentable columns. The act of contributing a column periodically on the topic of wine is consistent with the philosophy embodied in his pseudonym, i.e., to "lighten up" (from 'Jitterbug Perfume' by Tom Robbins).

Erleichda holds a PhD in microbiology following a baccalaureate in the same discipline. Post-doctoral training was received in tumor immunology and virology. While initial employment involved transplantation immunology research for a few years, a subsequent job at a research institute focused his attention on experimental chemotherapy and tumor biology. For the past nearly 30 years, Erleichda has worked in the pharmaceutical industry as a cancer drug developer. In that time, he has contributed substantially to the evaluation and development of scores of advanced compounds, culminating in the introduction of more than a dozen drug candidates to clinical trial, and continues to shepherd several of them toward satisfying unmet medical needs. With his colleagues, Erleichda has brought many of today's well known anticancer drugs to our armamentarium against this family of diseases.

The search for new anticancer therapeutics, and interest in natural products especially, led to the meeting of Abel Pharmboy and Erleichda, who, whenever the opportunity permits, continue to work together in this vein.

When not engaged in cancer drug development, Erleichda can be found hiking in Europe, "wherever grapes grow" he says, playing bridge on-line (listening to his personalized "Billie Holiday" station on Pandora.com) while glancing outside at the peafowl he keeps, playing a few games of racquetball, collecting medieval coins, and, of course, entertaining friends while sampling many wines.

Post a Comment

(Email is required for authentication purposes only. Comments are moderated for spam, your comment may not appear immediately. Thanks for waiting.)





Having problems commenting? (UPDATED)

Blogs in the Network

Advertisement

Top Five: Most Active

  1. Ray Comfort gets it half right 12.01.2008 · PZ Myers
  2. I'm sure it was just an unfortunate pratfall 12.01.2008 · PZ Myers
  3. Catholic Theocrats 12.01.2008 · Ed Brayton
  4. Anti-blasphemy = anti-free speech 12.01.2008 · Orac
  5. A simple question 12.01.2008 · DrugMonkey

Search All Blogs